Clinical Trials Logo

Major Depression in Remission clinical trials

View clinical trials related to Major Depression in Remission.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05166798 Completed - Clinical trials for Major Depression in Remission

Optimal Dose of a Cognitive Control Training for Depression Vulnerability

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This study aims to examine the dose-response relationship of an online adaptive cognitive control training on depressive symptomatology and rumination. Participants will be randomized over six groups, each receiving a different dose (0, 1, 5, 10, 15 or 20 sessions) of a cognitive control training in remitted depressed patients. An adaptive Paced Auditory Serial Addition Task will be used as cognitive control training.

NCT ID: NCT03278756 Completed - Clinical trials for Major Depression in Remission

Online Cognitive Control Training for Remitted Depressed Patients

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients. Half of the participants will receive a cognitive control training, while the other half will receive a low cognitive load training that acts as an active control condition.

NCT ID: NCT02407652 Completed - Clinical trials for Major Depression in Remission

Cognitive Control Training for Remitted Depressed Patients

Start date: December 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients.

NCT ID: NCT02226042 Completed - Clinical trials for Major Depression (in Remission)

Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)

Start date: October 2014
Phase: N/A
Study type: Interventional

This research will investigate the neuropsychological mechanisms underlying the eight-week Mindfulness-based Cognitive Therapy (MBCT) programme. Participants in remission from depression will be seen pre- and post-MBCT to assess the underlying neuropsychological mechanisms. All will be followed-up over 12 months to assess the relationship of these neuropsychological changes with relapse risk. The research will focus primarily on changes in self-compassion, rumination, attention and structural brain changes, with secondary focus on other mechanisms of emotional processing and memory.